Marcel Hoppentocht

767 total citations
9 papers, 623 citations indexed

About

Marcel Hoppentocht is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Marcel Hoppentocht has authored 9 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 2 papers in Epidemiology and 2 papers in Physiology. Recurrent topics in Marcel Hoppentocht's work include Inhalation and Respiratory Drug Delivery (7 papers), Cystic Fibrosis Research Advances (4 papers) and Asthma and respiratory diseases (2 papers). Marcel Hoppentocht is often cited by papers focused on Inhalation and Respiratory Drug Delivery (7 papers), Cystic Fibrosis Research Advances (4 papers) and Asthma and respiratory diseases (2 papers). Marcel Hoppentocht collaborates with scholars based in Netherlands, Belgium and Italy. Marcel Hoppentocht's co-authors include Paul Hagedoorn, Henderik W. Frijlink, Anne H. de Boer, Floris Grasmeijer, Francesca Buttini, Onno W. Akkerman, Candice Hoste, Jan‐Willem C. Alffenaar, Tjip S. van der Werf and Huib A.M. Kerstjens and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Marcel Hoppentocht

9 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcel Hoppentocht Netherlands	7	574	173	168	115	103	9	623
Yoen‐Ju Son United States	15	645 1.1×	175 1.0×	225 1.3×	98 0.9×	111 1.1×	19	717
Floris Grasmeijer Netherlands	16	714 1.2×	256 1.5×	228 1.4×	108 0.9×	129 1.3×	31	831
Handoko Adi Australia	21	730 1.3×	336 1.9×	300 1.8×	74 0.6×	171 1.7×	28	906
David Prime United Kingdom	11	682 1.2×	211 1.2×	223 1.3×	229 2.0×	92 0.9×	21	763
Jagdeep Shur United Kingdom	18	734 1.3×	322 1.9×	266 1.6×	83 0.7×	174 1.7×	29	894
Mohammed A. Boraey Egypt	10	371 0.6×	292 1.7×	177 1.1×	36 0.3×	102 1.0×	29	596
Peter H. Hirst United Kingdom	16	817 1.4×	172 1.0×	200 1.2×	308 2.7×	102 1.0×	20	952
Donghao Chen Australia	7	441 0.8×	203 1.2×	206 1.2×	43 0.4×	67 0.7×	9	501
Margaret D. Louey United States	9	458 0.8×	207 1.2×	195 1.2×	51 0.4×	121 1.2×	11	575
Gary R. Pitcairn United Kingdom	20	999 1.7×	124 0.7×	174 1.0×	474 4.1×	94 0.9×	32	1.1k

Countries citing papers authored by Marcel Hoppentocht

Since Specialization

Citations

This map shows the geographic impact of Marcel Hoppentocht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Hoppentocht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Hoppentocht more than expected).

Fields of papers citing papers by Marcel Hoppentocht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Hoppentocht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Hoppentocht. The network helps show where Marcel Hoppentocht may publish in the future.

Co-authorship network of co-authors of Marcel Hoppentocht

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Hoppentocht. A scholar is included among the top collaborators of Marcel Hoppentocht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Hoppentocht. Marcel Hoppentocht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hoppentocht, Marcel, Onno W. Akkerman, Paul Hagedoorn, et al.. (2016). Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients. PLoS ONE. 11(3). e0149768–e0149768. 24 indexed citations

Boer, Anne H. de, Paul Hagedoorn, Marcel Hoppentocht, et al.. (2016). Dry powder inhalation: past, present and future. Expert Opinion on Drug Delivery. 14(4). 499–512. 215 indexed citations

Hagedoorn, Paul, et al.. (2016). In vitroevaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe. Data Archiving and Networked Services (DANS). PA2561–PA2561. 6 indexed citations

Hoppentocht, Marcel, et al.. (2015). Optimisation of the sensitivity of an immunoassay analysis for tobramycin in serum. SHILAP Revista de lepidopterología. 1(4). 123–127. 3 indexed citations

Hoppentocht, Marcel, Onno W. Akkerman, Paul Hagedoorn, Henderik W. Frijlink, & Anne H. de Boer. (2015). The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family. European Journal of Pharmaceutics and Biopharmaceutics. 90. 8–15. 49 indexed citations

Hoppentocht, Marcel, Paul Hagedoorn, Henderik W. Frijlink, & Anne H. de Boer. (2014). DESIGN AND DEVELOPMENT OF A DISPOSABLE HIGH DOSE DRY POWDER INHALER FOR AMINOGLYCOSIDES. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(4). 2 indexed citations

Hoppentocht, Marcel, Paul Hagedoorn, Henderik W. Frijlink, & Anne H. de Boer. (2014). Technological and practical challenges of dry powder inhalers and formulations. Advanced Drug Delivery Reviews. 75. 18–31. 241 indexed citations

Hoppentocht, Marcel, Candice Hoste, Paul Hagedoorn, Henderik W. Frijlink, & Anne H. de Boer. (2014). In vitro evaluation of the DP-4M PennCentury™ insufflator. European Journal of Pharmaceutics and Biopharmaceutics. 88(1). 153–159. 33 indexed citations

Hoppentocht, Marcel, Paul Hagedoorn, Henderik W. Frijlink, & Anne H. de Boer. (2013). Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 86(1). 23–30. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact